HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Different methods of enhancing the efficacy of topical tacrolimus in extra-facial vitiligo: A comparative study.

AbstractBACKGROUND:
Vitiligo is an acquired pigmentation disorder due to loss of melanocytes. Topical tacrolimus is effective in vitiligo treatment with minimal effect on extra-facial lesions.
OBJECTIVE:
To assess different methods of enhancing the absorption of topical tacrolimus in extra-facial vitiligo sites using microneedling and occlusion.
METHODS:
This study included 20 adult patients of both sexes with non-segmental vitiligo. Four extra-facial vitiligo lesions in each patient were randomly labeled A, B, C, and D and treated as follows: area A: tacrolimus ointment (0.03%) application twice/day, area B: microneedling once/week and tacrolimus ointment application directly after microneedling and twice/day the rest of the week, area C: microneedling once/week alone, and area D: tacrolimus ointment application twice/day under occlusion by polyethylene foil. The evaluation was done clinically by calculating the re-pigmentation percent after 6 months of treatment.
RESULTS:
Responders in area B were 45%, and 35% in area C, and 25% in both areas A and D. No statistically significant difference was detected regarding the re-pigmentation percent between the four areas (p > 0.05). No correlations were detected between re-pigmentation percent and patients' data.
CONCLUSION:
Combination of microneedling and topical tacrolimus has an edge over monotherapy in vitiligo, and further studies are needed to verify such results.
AuthorsSamia M Esmat, Heba Ismail Gawdat, Rehab A Hegazy, Farah Sayed Ahmed, Eman Raafat Said
JournalJournal of cosmetic dermatology (J Cosmet Dermatol) Vol. 20 Issue 11 Pg. 3545-3551 (Nov 2021) ISSN: 1473-2165 [Electronic] England
PMID33626213 (Publication Type: Journal Article, Randomized Controlled Trial)
Copyright© 2021 Wiley Periodicals LLC.
Chemical References
  • Tacrolimus
Topics
  • Adult
  • Face
  • Female
  • Humans
  • Male
  • Pigmentation Disorders
  • Tacrolimus
  • Treatment Outcome
  • Vitiligo (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: